As the global biopharmaceutical landscape shifts toward more sophisticated therapeutic modalities—ranging from complex monoclonal antibodies to next-generation viral vector vaccines—the...
At the 2026 BioProcess International (BPI) East conference, CDMO GBI Biomanufacturing has officially unveiled its new "SmartScale™ GMP Solutions" platform....
In a bold strategic pivot that underscores the pharmaceutical industry's growing fascination with incretin-based therapies, Eli Lilly and Company has...
BOSTON — As the biopharmaceutical industry accelerates the development of complex modalities such as gene therapies, the pressure to optimize...
For decades, the medical community has sought a breakthrough in the treatment of Huntington’s disease (HD), a devastating, inherited neurological...
In a landmark development for the biotechnology and pharmaceutical research sectors, Molecular Devices and STEMCELL Technologies have announced the successful...
Diabetic kidney disease (DKD), a devastating complication affecting approximately 40% of individuals living with diabetes, has long been viewed through...
High-grade glioma (HGG), a collection of devastating and highly aggressive brain tumors, has long presented a formidable challenge to oncologists...
The landscape of genetic engineering is undergoing a tectonic shift. For over a decade, the CRISPR-Cas9 system has dominated the...
In the ongoing global battle against antibiotic-resistant pathogens, researchers at Virginia Tech have unveiled a groundbreaking approach to gut health...
In a significant stride toward deciphering the biological architecture of attention-deficit/hyperactivity disorder (ADHD), a team of researchers at the University...
The cell therapy landscape is currently undergoing a radical transformation, shifting from artisanal, labor-intensive manufacturing processes toward highly automated, industrial-scale...
